|
Market Closed -
Nasdaq
21:30:00 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2.278 USD | -6.45% |
|
-21.45% | -82.13% |
| 11-16 | Scienture Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 10-28 | Scienture Holdings, Inc. - Shareholder/Analyst Call |
| Market Cap | 3.74M 3.41M 3.14M 2.86M 5.36M 346M 5.63M 38.22M 15.19M 189M 14.04M 13.74M 594M | P/E 2026 * |
-0.24x | P/E 2027 * | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 3.74M 3.41M 3.14M 2.86M 5.36M 346M 5.63M 38.22M 15.19M 189M 14.04M 13.74M 594M | EV / Sales 2026 * |
1.2x | EV / Sales 2027 * | 0.24x |
| Free-Float |
71.58% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNX | Delayed | |
| 4E40 | Real-time | ||
| SCNX | Real-time | ||
| 4E40 | Delayed |
Last Transcript: Scienture Holdings, Inc.
| 1 day | -6.45% | ||
| 1 week | -21.45% | ||
| Current month | -29.26% | ||
| 1 month | -21.59% | ||
| 3 months | -79.74% | ||
| 6 months | -77.22% | ||
| Current year | -82.13% |
| 1 week | 2 | 3.27 | |
| 1 month | 2 | 3.68 | |
| Current year | 2 | 16.11 | |
| 1 year | 2 | 18.75 | |
| 3 years | 2 | 335.5 | |
| 5 years | 2 | 335.5 | |
| 10 years | 2 | 335.5 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/09/24 | Conversion | Director | 2,927,538 | - | ||
| 19/09/24 | Conversion | Chief Executive Officer | 3,853,296 | - | ||
| 25/07/24 | Other | Director | 57,977 | 4.1225% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.45% | -21.45% | -82.75% | - | 3.74M | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | -0.35% | -6.19% | +14.24% | +75.64% | 407B | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.11M 2.83M 2.61M 2.37M 4.45M 288M 4.68M 31.76M 12.62M 157M 11.66M 11.42M 494M | 15.47M 14.09M 12.98M 11.81M 22.16M 1.43B 23.29M 158M 62.81M 782M 58.05M 56.82M 2.46B |
| Net income | -15.33M -13.96M -12.86M -11.7M -21.95M -1.42B -23.07M -157M -62.23M -775M -57.51M -56.3M -2.43B | -6.27M -5.71M -5.26M -4.78M -8.98M -580M -9.43M -64.01M -25.44M -317M -23.51M -23.02M -995M |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | US$2.278 | -6.45% | 29,858 |
| 19/11/26 | US$2.435 | -4.51% | 38,586 |
| 18/11/26 | US$2.550 | -7.61% | 91,089 |
| 17/11/26 | US$2.760 | -7.69% | 15,460 |
| 16/11/26 | US$2.990 | +3.10% | 89,385 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.278USD
Average target price
6.000USD
Spread / Average Target
+163.40%
- Stock Market
- Stocks
- SCNX Stock
Select your edition
All financial news and data tailored to specific country editions
















